Ars Pharmaceuticals Inc (SPRY)
CapEx to Revenue
0.00%
Quarterly · Period ending:
SPRY CapEx to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
SPRY Quarterly CapEx/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
SPRY capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0.6061% | |
| 0.3245% | |
| 1.1414% | |
| 0.3488% | |
| 6.7698% | |
| 7.6% | |
| 0% | |
| 0% | |
| 0% | |
| 300% | |
| 965% | |
| 0% | |
| 15.873% | |
| 4.7414% | |
| 3.1674% | |
| 72.9443% | |
| 16.4773% | |
| 33.1439% | |
| 1.6572% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |